Evidence map›Paper›PMID 42039279›Full record

ArticleActa pharmaceutica Sinica. B2026

Engineered bacteria reprogram tumor microenvironment

Wanfa Dong, Chenyang Li, Jiqiang Lu, Lin Weng, Yicong Xu, Min Xu, Peiqi Li, Yanhui Wu, Zixuan Shan, Pengyou Shang and 8 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Acta pharmaceutica Sinica. B, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Formic acid released by intratumoralActa pharmaceutica Sinica. B · 2026
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Wanfa DongSchool of Biopharmacy, China Pharmaceutical University, Nanjing 211198, China.
Chenyang LiThe State Key Laboratory of Pharmaceutical Biotechnology, College of Life Sciences, Nanjing University, Nanjing 210023, China.
Jiqiang LuSchool of Biopharmacy, China Pharmaceutical University, Nanjing 211198, China.
Lin WengSchool of Biopharmacy, China Pharmaceutical University, Nanjing 211198, China.
Yicong XuThe State Key Laboratory of Pharmaceutical Biotechnology, College of Life Sciences, Nanjing University, Nanjing 210023, China.
Min XuSchool of Biopharmacy, China Pharmaceutical University, Nanjing 211198, China.
Peiqi LiSchool of Biopharmacy, China Pharmaceutical University, Nanjing 211198, China.
Yanhui WuSchool of Biopharmacy, China Pharmaceutical University, Nanjing 211198, China.
Zixuan ShanSchool of Biopharmacy, China Pharmaceutical University, Nanjing 211198, China.
Pengyou ShangSchool of Biopharmacy, China Pharmaceutical University, Nanjing 211198, China.
Liangliang DaiSchool of Biopharmacy, China Pharmaceutical University, Nanjing 211198, China.
Tao ZhangFaculty of Pharmaceutical Sciences, Xinxiang Medical University, Xinxiang 453003, China.
Yanlong JiaFaculty of Pharmaceutical Sciences, Xinxiang Medical University, Xinxiang 453003, China.
Tianyun WangFaculty of Pharmaceutical Sciences, Xinxiang Medical University, Xinxiang 453003, China.
Wenjie RenFaculty of Pharmaceutical Sciences, Xinxiang Medical University, Xinxiang 453003, China.
Ping LuFaculty of Pharmaceutical Sciences, Xinxiang Medical University, Xinxiang 453003, China.
Xiao ChenSchool of Biopharmacy, China Pharmaceutical University, Nanjing 211198, China.
Zichun HuaSchool of Biopharmacy, China Pharmaceutical University, Nanjing 211198, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Attenuated

Indexed as

Cancer immunotherapyCellular senescenceNETosisNeutrophilOncolytic bacteriaStaphylococcal nucleaseT cell exhaustionVNP20009

Identifiers

PMID42039279
PMCPMC13104682

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.